此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies (EASY-HD)

2026年6月26日 更新者:Olivier F. Bertrand

Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies: EASY-HD Pilot Study

The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are:

  • The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care
  • Reducing anxiety limits the use of pharmacological agents, which increases patient safety.

Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress.

Participants will:

  • listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure,
  • Answer pain, anxiety and recovery questionnaires,
  • Answer satisfaction questionnaires.

研究概览

详细说明

The EASY-HD project is a prospective, randomized, controlled pilot study to evaluate the effectiveness of immersive nonpharmacological strategies, soundscapes, and virtual reality (VR) on the reduction of intraprocedural anxiety and stress in patients undergoing a scheduled hemodynamic intervention (coronary angiography and/or angioplasty).

Adult patients will be included and randomized into three parallel groups (1:1:1): standard of care alone (control group), standard of care combined with relaxing soundscapes via headphones, or standard of care combined with virtual reality immersion in a soothing environment including sound. The devices will be set up 5 to 10 minutes before the procedure and continued througout.

This minimal-risk study aims to determine the feasibility and potential clinical benefit of these simple, reproducible non-pharmacological approaches to improve patient comfort and possibly reduce the need for hemodynamic sedation.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Quebec
      • Québec、Quebec、加拿大、G1V 4G5

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Adults, 18 years or older
  • Scheduled hemodynamic intervention (coronary angiography and/or angioplasty)
  • Patient willing and able to understand the study
  • Signed informed consent

Exclusion Criteria:

  • Scheduled complex procedure (CTO, structural)
  • Severe cognitive or psychiatric disorders
  • Major hearing/visual impairment
  • Severe motion sickness or history of malaise with Virtual Reality (VR)
  • Complaints of nausea or vomiting
  • History of epilepsy
  • Claustrophobia
  • Facial injuries
  • In clinical isolation (infection control)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Control
Standard of care analgesic and anxiolytic therapy
实验性的:Auditive experience
A pre-defined non-invasive audio experience using relaxing soundscapes via headphones will be used along standard of care pain and anxiety-relief medication (on patient's demand).
Auditive distraction therapy
实验性的:Immersion experience
A pre-defined virtual-reality led audiovisual experience will be used along standard of care pain and anxiety-relief medication (on patient's demand).
Virtual reality-lead audiovisual experience

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in patient-reported anxiety
大体时间:Baseline (preprocedural), periprocedural and at one-week follow-up

Change from baseline in patient reported anxiety evaluated by anxiety questionnaires

Visual Analog Score for anxiety (0 = Not anxious at all - 10 = Extremely anxious)

Baseline (preprocedural), periprocedural and at one-week follow-up
Change in patient-reported anxiety
大体时间:Baseline, Periprocedural, and at one-week follow-up

Change from baseline in patient reported anxiety evaluated by anxiety questionnaires

State-Trait Anxiety Invetory for Adults - 6 item short form

Baseline, Periprocedural, and at one-week follow-up
Change in patient-reported pain
大体时间:Baseline, periprocedural and at one-week follow-up

Change from baseline in patient reported pain evaluated by pain questionnaires

Visual Analog Scale for pain (0=No pain - 10 = Worst pain possible)

Baseline, periprocedural and at one-week follow-up

次要结果测量

结果测量
措施说明
大体时间
Use of analgesic and anxiolytic medications
大体时间:Within 48 hours before and after the procedure

Use vs no-use of analgesic (opioid/non-opioid) and/or anxiolytic medication.

If analgesic and/or anxiolytic medication is used, its type, dose and frequency will be registered.

Within 48 hours before and after the procedure
Change from baseline in physiological factors associated with pain and anxiety - Heart Rate
大体时间:Baseline, periprocedural
Heart rate (beats per minute)
Baseline, periprocedural
Change from baseline in physiological factors associated with pain and anxiety - Respiratory Rate
大体时间:Baseline, periprocedural
Respiratory rate (breaths per minute)
Baseline, periprocedural
Change from baseline in physiological factors associated with pain and anxiety - Blood Pressure
大体时间:Baseline, Periprocedural
Blood pressure (mmHg)
Baseline, Periprocedural
Incidence of adverse events of interest
大体时间:Within 10 days of the procedure
Patient-reported nausea, dizziness and increased anxiety will be collected
Within 10 days of the procedure

其他结果措施

结果测量
大体时间
Incidence of adverse cardiac events
大体时间:Within 10 days of the procedure
Within 10 days of the procedure

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2027年3月1日

研究注册日期

首次提交

2026年5月29日

首先提交符合 QC 标准的

2026年6月26日

首次发布 (实际的)

2026年7月2日

研究记录更新

最后更新发布 (实际的)

2026年7月2日

上次提交的符合 QC 标准的更新

2026年6月26日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他研究编号

  • EASY-HD

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅